학술논문
POSTER: CLL-585 Real-World Assessment of Dosing Patterns and Treatment Outcomes in Patients With Chronic Lymphocytic Leukemia Who Initiated First-Line Single-Agent Ibrutinib in an Integrated Claims-Based Database
Document Type
Abstract
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S173-S173
Subject
Language
ISSN
2152-2650